This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Aetiology

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Myasthenia gravis an autoimmune disease in which antibodies result in a loss of muscle acetylcholine (ACh) receptors (AChRs). In 85% of cases the antibodies bind to the AChRs themselves ('seropositive') and in the remaining cases (misleadingly described as 'seronegative') the antibodies bind to a different muscle membrane target (1).

Neonatal myasthenia may result from the antibody being passively transferred to a fetus in utero. This condition will be transient.

There are associations between myasthenia gravis and thymic hyperplasia - 75% of cases - and thymoma -15%. Antibodies to striated muscle are usually present in the latter group.

The condition may be exacerbated by drugs, e.g. penicillamine, lithium, aminoglycosides, and phenytoin.

Reference:

  • Prescribers' Journal 2000; 40 (2): 93-96.
  • Jeffrey M. Statland, Emma Ciafaloni. Myasthenia gravis: Five new things Neurol Clin Pract. 2013 April; 3(2): 126-133.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.